Amio, Lido or Placebo?... Turns out it doesn't matter.

Haven't we basically known this since circa 2000? Why did we need ANOTHER study to confirm it.

Anti-dysrhythmics are useful in the peri-arrest phase....not so much intra-arrest.
 
I have no doubt this will result in practice changes and alterations to the ACLS algorithm. </sarcasm>
 
Sorry about that, not a study really, but I believe that procainimide is a class 1a and amiodarone is a 2b in treating stable v tach at least.
Stable vt is different from intraarrest

Also,1a and 2b are you talking about levels of evidence/recommendation class? Because those come from studies / studies+concensus(from a particular organization).

Or are you talking about antiarrhythmic classes? Because amio is a class 3.
 
Last edited:
Yeah I understand the difference between the two, and I was talking about the recommendation classes.
 
Yeah I understand the difference between the two, and I was talking about the recommendation classes.
With the recommendation classes, I associated that with a podcast I heard from emcrit about new ACLS stuff about a higher survival rate. I just mistakenly associated it with arrest instead of stable v tach.
 
Haven't we basically known this since circa 2000? Why did we need ANOTHER study to confirm it.

Just to clarify: 1. Nope. 2. There wasn't a first, but one of the most important aspects to science is replication, so hopefully there will be ANOTHER study.
 
Back
Top